Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-08-14 | Keith L. Brownlie, CPA has been a director since June 2011. The Board of Directors has an Audit Committee, which is comprised of Mr. Brownlie (Chair), Mr. Lapointe and Dr. Rubin. The Compensation Committee is comprised of Dr. Rubin (Chair), Mr. Brownlie and Dr. Zeldis. The Nominating and Corporate Governance Committee is comprised of Dr. Zeldis (Chair), Mr. Brownlie and Mr. Lapointe. The following table contains information concerning the compensation of the non-employee directors during the fiscal year ended December 31, 2012. Keith Brownlie received $56,250 in fees and $7,500 in option awards, totaling $63,750. |
| 2014-05-08 | Keith L. Brownlie, CPA has been a director since June 2011. Mr. Brownlie currently serves on the Board of Directors of RXi Pharmaceuticals Corporation... The Board of Directors has the following three committees: (1) Compensation, (2) Audit and (3) Nominating and Corporate Governance. The Board of Directors has adopted a written charter for each of these committees... Keith L. Brownlie, CPA - Audit Committee (Chair), Compensation Committee, Nominating and Corporate Governance Committee... Compensation of Directors: Keith Brownlie - Fees Earned Paid in Cash $60,000, Option Awards $30,000, Total $90,000. |
| 2015-05-01 | Keith L. Brownlie, CPA has been a director since June 2011. Mr. Brownlie currently serves on the Board of Directors of Rxi Pharmaceuticals Corporation... Mr. Brownlie was selected to serve as a member of our Board of Directors because of his vast experience as an audit partner for numerous public companies and as a director of publicly traded specialty pharmaceutical and biotechnology companies. |
| 2016-05-02 | Keith L. Brownlie, CPA has been a director since June 2011. Mr. Brownlie currently serves on the Board of Directors of Rxi Pharmaceuticals Corporation... The Audit Committee is comprised of Mr. Brownlie (Chair)... The Nominating and Corporate Governance Committee is comprised of Dr. Zeldis (Chair), Mr. Brownlie and Mr. Lapointe... Compensation of Directors: Keith L. Brownlie Fees Earned Paid in Cash $55,000, Option Awards $30,000, Total $85,000. |
| 2017-04-28 | Keith L. Brownlie, CPA has been a director since June 2011. Mr. Brownlie currently serves on the Board of Directors of Rxi Pharmaceuticals Corporation... The Audit Committee is comprised of Mr. Brownlie (Chair)... The Nominating and Corporate Governance Committee is comprised of Dr. Zeldis (Chair), Mr. Brownlie and Mr. Lapointe... The following table contains information concerning the compensation of the non-employee directors during the fiscal year ended December 31, 2016. Keith L. Brownlie Fees Earned Paid in Cash $55,500 Option Awards $30,000 Total $85,000. |
| 2018-08-10 | Keith L. Brownlie 66 Director |
| 2019-07-26 | Keith L. Brownlie, CPA has been a director since June 2011. Our Board of Directors has an Audit Committee, which is comprised of Mr. Brownlie (Chair), Mr. Lapointe and Dr. Rubin. Our Board of Directors has a Nominating and Corporate Governance Committee, which is comprised of Dr. Zeldis (Chair), Mr. Brownlie and Mr. Lapointe. The following table contains information concerning the compensation of the non-employee directors during the year ended December 31, 2018. Keith L. Brownlie: Fees Earned Paid in Cash: $55,000, Option Awards: $30,000, Total: $85,000. |
Data sourced from SEC filings. Last updated: 2025-12-06